GO
Loading...

St. Jude Medical Inc

More

  • Will earnings tell the story markets need to hear? Friday, 11 Jul 2014 | 5:53 PM ET
    Traders work the floor of the New York Stock Exchange before the closing bell in New York.

    Quarterly earnings growth and clues from companies' commentaries will tell whether there really will be a bounce back in growth in the second half.

  • Midday Glance: Medical Devices companies Friday, 11 Jul 2014 | 1:37 PM ET

    Allergan rose$. 08 or percent, to $165.68. Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Boston Scientific Corp. fell$. 07 or. 5 percent, to $13.03.

  • Early Glance: Medical Devices companies Friday, 11 Jul 2014 | 10:30 AM ET

    Allergan fell$. 62 or. 4 percent, to $164.98. Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Boston Scientific Corp. fell$. 15 or 1.1 percent, to $12.95.

  • Midday Glance: Medical Devices companies Thursday, 10 Jul 2014 | 1:44 PM ET

    Allergan fell $1.06 or. 6 percent, to $164.14. Baxter International Inc. rose$. 65 or. 9 percent, to $76.47. Boston Scientific Corp. fell$. 01 or. 1 percent, to $13.01.

  • Early Glance: Medical Devices companies Thursday, 10 Jul 2014 | 11:01 AM ET

    Allergan fell $1.32 or. 8 percent, to $163.88. Baxter International Inc. fell$. 10 or. 1 percent, to $75.72. Boston Scientific Corp. fell$. 13 or 1.0 percent, to $12.89.

  • Midday Glance: Medical Devices companies Tuesday, 8 Jul 2014 | 1:41 PM ET

    Allergan fell$. 26 or. 2 percent, to $165.60. Baxter International Inc. rose$. 14 or. 2 percent, to $75.02. Boston Scientific Corp. fell$. 06 or. 4 percent, to $12.97.

  • Early Glance: Medical Devices companies Tuesday, 8 Jul 2014 | 10:30 AM ET

    Allergan fell$. 85 or. 5 percent, to $165.00. Baxter International Inc. fell$. 04 or. 1 percent, to $74.84. Boston Scientific Corp. fell$. 03 or. 2 percent, to $12.99.

  • Final Glance: Medical Devices companies Thursday, 3 Jul 2014 | 5:15 PM ET

    Allergan fell $1.42 or. 8 percent, to $169.13. Baxter International Inc. fell$. 11 or. 1 percent, to $74.88. Boston Scientific Corp. fell$. 02 or. 2 percent, to $13.11.

  • Midday Glance: Medical Devices companies Thursday, 3 Jul 2014 | 1:17 PM ET

    Allergan fell $1.50 or. 9 percent, to $169.05. Baxter International Inc. fell$. 11 or. 1 percent, to $74.88. Boston Scientific Corp. fell$. 02 or. 2 percent, to $13.11.

  • Early Glance: Medical Devices companies Thursday, 3 Jul 2014 | 10:30 AM ET

    Allergan fell$. 42 or. 2 percent, to $170.13. Baxter International Inc. fell$. 32 or. 4 percent, to $74.67. Boston Scientific Corp. fell$. 06 or. 5 percent, to $13.07.

  • July 2- St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California- based manufacturing plant have been resolved. The FDA last year had warned St.

  • July 2- St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California- based manufacturing plant have been resolved. The FDA last year had warned St. Jude of serious violations at the plant where the Durata and Riata leads for implantable defibrillators are made.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity Worldwide Investment, ranking 18th, backed the British company's stance.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity, ranking 18th, backed the British company's stance.

  • LONDON, May 20- AstraZeneca shareholder Schroders urged the company to restart takeover talks with Pfizer, adding its voice to criticism of the British drugmaker's rejection of the U.S. firm's 70 billion pound bid. Schroders is AstraZeneca's twelfth-largest shareholder with a 2 percent stake.

  • Boston Scientific gets subpoena over defibrillators Thursday, 8 May 2014 | 11:37 PM ET

    May 8- Medical device maker Boston Scientific Corp said it received a subpoena this week from the Department of Health and Human Services seeking information about the performance of some of its implanted defibrillators. Boston Scientific, which competes with Medtronic Inc and St. Jude Medical Inc in selling ICDs, said it is cooperating with the request.

  • NEW YORK, May 1- Invesco Ltd, which oversees the PowerShares line of exchange-traded funds, said on Thursday its first-quarter profit fell 15.5 percent, pressured by an increase in operating expenses that included a fine from British regulators. The fine reduced Invesco's quarterly diluted earnings per share by 7 cents, the company said.

  • April 29- Boston Scientific Corp's quarterly revenue fell short of expectations due to lower sales of its implantable defibrillators and pacemakers, sending its shares down as much as 6 percent. Boston Scientific said it expected subcutaneous ICD sales of over $75 million in 2014..

  • Early movers: BAC, PNC, YHOO, GM & more Wednesday, 16 Apr 2014 | 7:46 AM ET
    Traders on the floor of the New York Stock Exchange on April 11, 2014

    Some of the names on the move ahead of the open.